Stada will invest more than 85 million euros (around $101 million) to build a new production facility in Saudi Arabia, which will ultimately serve as a supply hub for the broader Middle East and North Africa region. The plant, which Stada expects to open by 2030, will create some 400 new jobs in the country.
Bayer has spent years working to get a handle on its Roundup legal mess. With a multibillion-dollar deal unveiled Tuesday, it's moving a step closer to that goal.
Shaped primarily by discussions with Gen Xers and older millennials, a new campaign from a coalition formed by the CDC Foundation is using a familiar aesthetic to educate adults about managing high blood pressure.
COMP360 could be the first psilocybin-based medicine to win approval.
The company is confident that results from a head-to-head trial against Regeneron's Eylea could make Axpaxli "one of the most consequential advances in retina," CEO Pravin Dugel, M.D., said in a statement. Investors were unimpressed, sending the biotech's shares down more than 25% Tuesday.
Six years after the FDA approved Eli Lilly’s Retevmo to treat lung and thyroid cancers with a rare biomarker, the Indianapolis drugmaker is laying groundwork to move the treatment into the adjuvant setting, reporting the success of a phase 3 trial of Retevmo in non-small cell lung cancer.
Continuing the reinvention of its cancer drug Gazyva as a treatment for immune-mediated diseases of the kidney—which resulted in a lupus nephritis nod last fall—Roche is touting new data that could tee up the antibody for a world-first approval.
Facing shrinking profits and higher costs, health insurers are accelerating adoption of AI throughout their sprawling operations.
To understand what China's fast-developing drug industry might mean for global pharmaceutical companies, look no further than the market for GLP-1 drugs.
Researchers investigating crops grown in soil contaminated by the 2015 mining disaster in Brazil discovered that toxic metals are moving from the earth into edible plants. Bananas, cassava, and cocoa were found to absorb elements like lead and cadmium, with bananas showing a potential health risk for children under six. Although adults face lower immediate danger, scientists warn that long-term ex
An Ice Age double burial in Italy has yielded a stunning genetic revelation. DNA from a mother and daughter who lived over 12,000 years ago shows that the younger had a rare inherited growth disorder, confirmed through mutations in a key bone-growth gene. Her mother carried a milder version of the same mutation. The finding not only solves a long-standing mystery but also proves that rare genetic
Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pi
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across dozens of tumor types. These molecules form unique molecular signatures that identify cancer type and subtype with remarkable accuracy. Some even drive tumor growth and metastasis. Because many are released into the bloodstream, a simple blood test can track how patients respond
A decades-long study of nearly 200,000 adults challenges the low-carb versus low-fat debate. Both eating patterns were tied to lower heart disease risk when they emphasized whole grains, plant-based foods, and healthy fats. Versions filled with refined carbs and animal fats increased risk instead. Quality, not just quantity, appears to make the difference.
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, CRISPR, and quantum dots to generate a clear signal from just a few molecules. In lung cancer tests, it worked even in real patient serum samples. Researchers hope it could eventually power portable blood
Amid major changes to Medicare Advantage, some big insurers have been working to shrink their rolls.
In a time of uncertainty, the public health campaign to save the CDC Injury Center offers important lessons — and hope.
What does it feel like to live in a house where your parents are getting divorced? Just ask some of the staff at Dana-Farber Cancer Institute.
A parasite that may already be hiding in your brain has a shocking survival trick: it can infect the very immune cells sent to destroy it. Yet most people never get sick, and new research from UVA Health reveals why. Scientists discovered that when Toxoplasma gondii invades CD8+ T cells — key defenders of the immune system — those cells can trigger a self-destruct mechanism powered by an enzyme ca
Researchers have built a realistic human mini spinal cord in the lab and used it to simulate traumatic injury. The model reproduced key damage seen in real spinal cord injuries, including inflammation and scar formation. After treatment with fast moving “dancing molecules,” nerve fibers began growing again and scar tissue shrank. The results suggest the therapy could eventually help repair spinal